Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Bioregenx (BRGX) FCF Margin (2022 - 2025)

Bioregenx's FCF Margin history spans 4 years, with the latest figure at 17.26% for Q4 2025.

  • Quarterly results put FCF Margin at 17.26% for Q4 2025, up 1973.0% from a year ago — trailing twelve months through Dec 2025 was 1.61% (up 2356.0% YoY), and the annual figure for FY2025 was 1.61%, up 2356.0%.
  • FCF Margin for Q4 2025 was 17.26% at Bioregenx, up from 15.28% in the prior quarter.
  • In the past five years, FCF Margin ranged from a high of 17.26% in Q4 2025 to a low of 271.55% in Q1 2022.
  • The 4-year median for FCF Margin is 33.49% (2023), against an average of 53.76%.
  • The sharpest move saw FCF Margin skyrocketed 24023bps in 2023, then plummeted -2212bps in 2024.
  • Year by year, FCF Margin stood at 48.96% in 2022, then grew by 26bps to 36.23% in 2023, then skyrocketed by 93bps to 2.47% in 2024, then skyrocketed by 800bps to 17.26% in 2025.
  • According to Business Quant data, FCF Margin over the past three periods came in at 17.26%, 15.28%, and 0.72% for Q4 2025, Q3 2025, and Q2 2025 respectively.